20/20 Biolabs, Inc. (AIDX)
Market Closed
11 Aug, 20:00
NASDAQ (NMS) NASDAQ (NMS) Primary $
0. 44
-0.02
-4.8546%
After Hours
$
+0.07 +15.7895% 0. 50
2.58M Market Cap
- P/E Ratio
- Div Yield
60,814 Volume
- Eps
$ 0.46
Previous Close Want to track AIDX and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
20/20 Biolabs, Inc. (AIDX) Statistics
Valuation metrics
Market Cap 2.58M
Enterprise value -726.28K
Trailing P/E (ttm) -0.78
Forward P/E -
PEG ratio -0.01
Price/Sales (ttm) 1.96
Price/Book (mrq) 1.26
Enterprise Value/Revenue -0.55
Enterprise Value/EBITDA 0.23
Overview
Shares outstanding -
Float -
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) 26.62K
Average volume (90 days) 618.61K
Price summary
52-Week low 0.4
52-Week high 50
Beta -
50-Day moving average 0.53
200-Day moving average 2.45
Financials
Fiscal year
Fiscal year ends -
Most recent quarter (mrq) -
Profitability
Profit margin -3.29%
Operating margin -2.41%
Operational effectiveness
Return on assets -0.74%
Return on equity 0.79%
Income Statement
Revenue (ttm) -
Revenue per share (ttm) 0.17
Quarterly revenue growth (yoy) -
Gross profit (ttm) -
EBITDA -
Net income to common (ttm) -
Diluted EPS (ttm) -0.56
Quarterly earnings growth (yoy) -
Balance Sheet
Total cash (mrq) -
Total cash per share (mrq) 0.55
Total debt (mrq) -
Total Debt/Equity (mrq) 0.34
Current ratio (mrq) 1.82%
Book value per share (mrq) 0.36
Cash Flow
Cash flow statement -
Levered free cash flow (LFCF) -
